Other News To Note
Monday, December 27, 2010
Oramed Pharmaceuticals Inc., of Jerusalem, was awarded a NIS2.9 million (US$807,000) grant from the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of Israel. The funding will support development of Oramed's oral insulin and oral GLP-1 analogue for diabetes.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.